MedTrace Logo

Biological Phosphocalcic Metabolism and Coronary Artery Calcifications

NCT02792868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2017-04-07

No results posted yet for this study

Summary

Study a sample of patients in primary prevention, moderate cardiovascular risk (n = 83 patients), with normal, non-diabetic renal function. The investigators quantify the phophocalcic intake and excretion, realizing a food examination and a urine collection of 24 particular. The investigators will measure plasma levels of FGF23 serum calcium, phosphatemia, the investigators will calculate the tubular reabsorption of phosphate. The investigators will conduct a quantitative assessment of coronary calcification by a non-injected CT scan, measuring semi automated way Agatston calcium score. There will be an analysis of collinearity. An adjustment will be made for confounding variables in a generalized linear regression model.

Conditions

Interventions

OTHER

24 h urines analyses

patient collects urines during 24h

Sponsors & Collaborators

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Jean FERRIERES · CHU RANGUEIL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792868 on ClinicalTrials.gov